MediGene AG Forecast, price target & analysts
€1.54
0.39%
yesterday
Xetra,
Mar 21, 05:35 pm CET
MediGene AG Target price 2025 - Analyst rating & recommendation
Powered by
MediGene AG Classifications & Recommendation:
Buy
100%
MediGene AG Price Target
| Target Price | €2.90 |
| Price | €1.54 |
| Potential |
88.31%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target MediGene AG 2026 .
The average MediGene AG target price is €2.90.
This is
88.31%
register free of charge
€3.80
146.75%
register free of charge
€2.00
29.87%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend MediGene AG to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediGene AG stock has an average upside potential 2026 of
88.31%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million € | 6.03 | 9.50 |
| 80.70% | 57.55% | |
| EBITDA Margin | -249.25% | -135.98% |
| 711.88% | 45.45% |
2 Analysts have issued a sales forecast MediGene AG 2024 . The average MediGene AG sales estimate is
€9.5m
Unlock
27.52%
higher
Unlock
€11.0m
47.65%
Unlock
€8.0m
7.38%
Unlock
This results in the following potential growth metrics:
2 Analysts have issued an MediGene AG EBITDA forecast 2024. The average MediGene AG EBITDA estimate is
€-12.9m
Unlock
9.41%
higher
Unlock
€-12.3m
13.74%
Unlock
€-13.5m
5.07%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 0.12 |
Current MediGene AG Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Dec 15 2024 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
